Continuous Versus Discontinuous Design of Encircling Lesions During Ablation for Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT03332862
- Lead Sponsor
- Institute for Clinical and Experimental Medicine
- Brief Summary
Acute efficacy of point-by-point radiofrequency ablation for pulmonary vein isolation in patients with atrial fibrillation are comparable independantly of the ablation strategy (continous versus discontinuous ablation) under the same condition of power delivery.
- Detailed Description
The number of pulmonary vein isolation (PVI) therapy for atrial fibrillation (AF) is increasing. Durable PVI is cornerstone for long-term freedom of AF. In one previous study continuous ablation was suggested to be more efficient in durable PVI. However, this hypothesis has not been proven in randomized fashion.
The current study is to confirm whether continuous versus discontinuous design of encircling lesions are comparable under the same conditions of power delivery.
The study design is a two-centre prospective randomized trial to compare the acute efficacy by using the above described approaches.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Patients undergoing pulmonary vein isolation with radiofrequency catheter ablation for paroxysmal atrial fibrillation treatment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Combined unsuccessful PVI or PV reconnection 30 min after ablation Combined unsuccessfuk PVI after completeing the primary lesion set or PV reconnection during the waiting time
- Secondary Outcome Measures
Name Time Method Early pulmunary veins reconnection 10 min. Early pulmunary veins reconnection within the first 10 min after PVI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Institute for Clinical and Experimental Medicine
🇨🇿Praha, Czechia
Institute for Clinical and Experimental Medicine🇨🇿Praha, CzechiaBashar Aldhoon, MD,PhDContact